Related Experiment Video

Updated: Aug 11, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides

Donald Kaye1

  • 1Department of Medicine, Drexel University, College of Medicine, 3300 Henry Avenue, Philadelphia, PA 19129, USA. donjank@aol.com

Infectious Disease Clinics of North America
|August 17, 2004
PubMed

Insights

This article reviews special-use antibacterial agents, including polymyxins, rifampin, and aminoglycosides, for treating uncommon bacterial infections beyond mycobacterial diseases.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Standard antibacterial therapies are widely used for common bacterial infections.
  • Certain bacterial infections require specialized antimicrobial agents due to resistance or specific pathogen characteristics.

Purpose of the Study:

  • To discuss three classes of antibacterial agents: polymyxins, rifampin, and aminoglycosides.
  • To highlight their uncommon but critical roles in treating specific bacterial infections (excluding mycobacterial infections).

Main Methods:

  • Literature review of clinical பயன்பாடு and mechanisms of action for polymyxins, rifampin, and aminoglycosides.
  • Analysis of scenarios where these special-use agents are indicated.

Main Results:

  • Polymyxins are effective against multidrug-resistant Gram-negative bacteria.
  • Rifampin is crucial for infections caused by staphylococci and in combination therapy.
  • Aminoglycosides remain important for severe Gram-negative infections and specific synergistic uses.

Conclusions:

  • Polymyxins, rifampin, and aminoglycosides are essential 'special-use' antibacterials.
  • Understanding their unique roles optimizes treatment for challenging bacterial infections.
  • These agents are vital components of the antimicrobial arsenal for specific clinical situations.

More Related Videos

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...